FinnCap restated their corporate rating on shares of Cambridge Cognition Holdings PLC (LON:COG) in a research note issued to investors on Thursday morning. They currently have a GBX 115 ($1.50) target price on the stock.

Cambridge Cognition Holdings PLC (LON:COG) opened at 83.00 on Thursday. Cambridge Cognition Holdings PLC has a 52 week low of GBX 30.00 and a 52 week high of GBX 103.70. The stock has a 50 day moving average price of GBX 65.79 and a 200-day moving average price of GBX 45.90. The stock’s market cap is GBX 15.47 million.

About Cambridge Cognition Holdings PLC

Cambridge Cognition Holdings plc is a holding company. The Company operates through its wholly owned subsidiary, Cambridge Cognition Limited (CCL). It develops and commercializes computerized neuropsychological tests for sale, principally in the United Kingdom, the United States and Europe. The Company has three segments: Healthcare, which includes medical software for use in healthcare delivery settings; Academic Research, which includes cognitive test products for researchers working in a non-regulated environment, and Clinical Trials, which includes products and services for use in regulated pharmaceutical clinical trials.

Receive News & Ratings for Cambridge Cognition Holdings PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition Holdings PLC and related companies with's FREE daily email newsletter.